Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.560
+0.100 (6.85%)
At close: Oct 9, 2026, 4:00 PM EDT
1.530
-0.030 (-1.92%)
After-hours: Oct 9, 2026, 7:55 PM EDT

Celularity Revenue

Celularity had revenue of $3.85M in the quarter ending March 31, 2026, a decrease of -66.34%. This brings the company's revenue in the last twelve months to $18.97M, down -62.78% year-over-year. In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. That makes Celularity the 34,087th largest company in the world by revenue and 4,488th in the United States.

Revenue (ttm)
$18.97M
Revenue Growth
-62.78%
P/S Ratio
2.67
Revenue / Employee
$164,957
Employees
115
Market Cap
50.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202526.55M-27.67M-51.03%
Dec 31, 202454.22M31.45M138.11%
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M--
Dec 31, 2019---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BioStem Technologies34.59M
Apollomics8.84M
ImageneBio800.00K
CervoMed331.30K
Serina Therapeutics130.00K
INmune Bio50.00K
eXoZymes-700.00
Revenue Rankings